Latest news with #BALO
Yahoo
06-06-2025
- Business
- Yahoo
Vantiva - Conditions of availability of information for the 20250630 CGM
Press Release Regulated information Conditions of availability of the preparatory documents(Art. 221-1 AMF General Regulation)Combined Shareholders' Meeting on June 30, 2025 Paris – June 6, 2025 – Vantiva (Euronext Paris: VANTI), a global technology leader in connectivity, Shareholders are invited to participate to the Combined Shareholders' Meeting to be held on: Monday, June 30, 2025 at 2 p.m.,Auditorium10 Boulevard de Grenelle – 75015 Paris (France) The Preliminary Notice of Meeting, including the agenda and the proposed resolutions, was published in the French Bulletin des Annonces Légales Obligatoires (BALO) on May 23, 2025 and a convening Notice of Meeting will be published in the Bulletin des Annonces Légales Obligatoires (BALO) and the journal of legal notices on June 11, 2025. Registered shareholders will receive their convening notice of meeting directly. Shareholders may request that the preparatory documents for this Meeting provided for in Article R.225-83 of the Commercial Code be sent to them by submitting a request in accordance with the conditions stipulated by the regulations. Any shareholder may also consult these documents at the Company's head office during a period of 15 days prior to the date of the Meeting. The documents and information relating to this General Meeting are available and can be downloaded by shareholders on the Vantiva website. About Vantiva Pushing the Edge Vantiva (Euronext Paris: VANTI) is a global technology leader in the Customer Premises Equipment (CPE) market. For over 130 years, Vantiva (formerly known as Technicolor) has delivered solutions that connect what matters most. Today, the company continues to redefine connectivity with industry-leading broadband, video, and IoT-driven smart systems that elevate how people live, work, and connect globally. Vantiva combines a customer-focused approach with decades of software development, electronics hardware design, and supply chain expertise to deliver high-quality solutions at scale. This proficiency has positioned Vantiva as a trusted provider to leading network service providers, enterprise customers, and consumers around the world. A strong commitment to sustainability and responsible business practices has earned Vantiva multiple Gold and Platinum Medals from EcoVadis for environmental and social performance. These awards place the company among the top 2% of organizations in its category evaluated globally. With its headquarters in Paris and major offices in Australia, Brazil, China, India, South Korea, the United Kingdom, and the United States, the company serves a diverse global customer base. For more information, please visit and follow Vantiva on LinkedIn and X (Twitter). Contacts Vantiva Press Relations Image 7 for Attachment Vantiva - Conditions of availability of information for the 20250630 CGM
Yahoo
05-06-2025
- Business
- Yahoo
Alstom S.A: 10 July 2025 Combined Shareholders' Meeting - Availability of the preparatory documents
5 June 2025 – ALSTOM's shareholders are invited to participate in the Combined Shareholders' Meeting of 10 July 2025 (the 'Meeting') which will take place at 2:00 PM at 28, avenue George V ('Châteauform' Le 28 George V') 75008 Paris. The Meeting will be broadcasted live and in full on the Company's website ( This broadcast will also be available on the Company's website on a deferred basis within the timeframes provided for by applicable regulations. The prior notice of the Meeting, which includes the Meeting agenda, the text of the resolutions submitted to the Meeting's approval and the main details about participating in and voting at the Meeting was published on 2 June 2025 in the Bulletin des Annonces Légales Obligatoires (BALO) n°66. The convening notice will be published in BALO and in a newspaper for legal notices on 23 June 2025. These notices may be consulted on the Company's website: Availability preparatory materials – Document transmittal requests The preparatory materials for the Meeting referred to in Article R. 22-10-23 of the French Commercial Code are available on the Company's website ( The documents that are to be presented to the Meeting in accordance with, in particular, Articles L. 225-115 and R. 225-83 of the French Commercial Code are available on the Company's website ( or upon request sent to the following email address: Shareholders are also invited to regularly consult the area dedicated to the Meeting on the Company's website ( About Alstom Alstom commits to contribute to a low carbon future by developing and promoting innovative and sustainable transportation solutions that people enjoy riding. From high-speed trains, metros, monorails, trams, to turnkey systems, services, infrastructure, signalling and digital mobility, Alstom offers its diverse customers the broadest portfolio in the industry. With its presence in 63 countries and a talent base of over 86,000 people from 184 nationalities, the company focuses its design, innovation, and project management skills to where mobility solutions are needed most. Listed in France, Alstom generated sales of €18.5 billion for the fiscal year ending on 31 March 2025. For more information, please visit Contacts Press:Philippe MOLITOR - Tel.: +33 (0) 7 76 00 97 ANTOINE - Tel.: +33 (0) 6 11 47 28 60 relations:Cyril GUERIN – Tel: +33 (0) 6 07 89 36 Guillaume GAUVILLE – Tel : +44 (0) 75 88 02 27 Estelle MATURELL ANDINO – Tel: +33 (0) 6 71 37 47 Jalal DAHMANE – Tel : +33 (0) 6 98 19 96 Attachment 20250605_PR_AGM_Preparatory_documents_ENError while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
04-06-2025
- Business
- Yahoo
Ose Immunotherapeutics : Documents made available to the shareholders for the combined general meeting of June 25th, 2025
Documents made available to the shareholders for the combined general meeting of June 25th, 2025 Nantes, June 4th, 2025, 8 a.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announces the publication of the preparatory documents for the combined general meeting to be held on June 25th, 2025 at 10 a.m. at the Drawing House Hotel - 21, rue Vercingétorix - 75014 Paris. The convening notice (avis de reunion valant avis de convocation) containing the agenda and the resolutions, as well as the conditions for attending and voting at this General Meeting, was published in the BALO on May 21st, 2025 and the convening notice will be published in the BALO and in a legal gazette on June 6th, 2025. The preparatory documents required by Article R. 22-10-23 of the French Commercial Code are available on the Company's website: In accordance with the applicable regulations: Registered shareholders may, up to and including the fifth calendar day before the General Meeting, ask the Company to send them the documents referred to in Articles R.225-81 and R.225-83 of the French Commercial Code, where applicable at their express request by electronic means. For shareholders in bearer form, the exercise of this right is subject to the provision of a certificate of participation in the accounts in bearer form held by the authorized intermediary. Any shareholder may consult the documents referred to in Articles L. 225-115 and R.225-83 of the French Commercial Code at the registered office of the Company (22, Boulevard Benoni Goullin - 44200 Nantes). Context of the General Meeting and commitment of the Board of Directors For several years, OSE has pursued a clear strategy aimed at creating sustainable value for all its shareholders. The Board of Directors ensures good governance, transparency of information and consistency of strategic decisions. It reiterates its commitment to balanced, independent governance focused on long-term value creation, in the interests of all shareholders. In this context, the Board invites shareholders to consider carefully the implications of the resolutions put to the vote, in particular those that may affect the stability and continuity of the implementation of the Company's strategy. For a better comprehension of the foundations and ambitions of the strategy pursued by the Board of Directors, shareholders are also invited to consult the press release published in parallel today, which sets out the Company's long-term objectives and outlook1. Competing resolutions proposed by a group of concerted shareholders In accordance with applicable regulations, the convening brochure sets out all the resolutions put to the vote, including ten draft resolutions proposed by a group of shareholders acting in concert, declaring holding approximately 24% of the voting rights under the terms of a shareholders' agreement published on June 3rd, 2025 on the AMF website2. The Board of Directors emphasizes that the sole purpose of these resolutions is to reorganize the Board of Directors almost entirely. If adopted, these resolutions would be particularly destabilizing for the governance of the Company, and the Board of Directors considers that they are likely to undermine its stability and interrupt the implementation of its strategy, to the detriment of its attractiveness, credibility and development trajectory. They appear disproportionate in view of the context, the governance in place and the effective representation of the initiating group. After careful consideration, the Board of Directors recommends voting against all the resolutions proposed by these shareholders. Detailed explanations and voting recommendations can be found in the convening brochure and in the communication to shareholders available on the company's website: Respect of shareholder democracy and governance principles The Company reaffirms its commitment to the proper functioning of the democratic process specific to general meetings, based on transparency, fairness between shareholders and respect for each shareholder's right to information. The Board of Directors draws the attention of shareholders to the resolutions proposed by the group of shareholders acting in concert, whose shareholders' agreement was not made public on the French financial market authority (Autorité des marchés financiers) website until June 3rd, 2025. At this stage, the elements made public are being carefully analyzed by the Company as to their completeness, timing and effective scope. The Company remains fully committed to ensure that the General Meeting will be conducted in a fair and transparent manner, while respecting the rights of all shareholders and the interests of the Company. In this respect, the Company reserves the right to take any appropriate action, including regulatory or legal action, should circumstances so require. The Board of Directors reiterates its commitment to balanced, independent governance focused on long-term value creation, in the interests of all shareholders. The brochure also sets out the terms and conditions for participation, distance voting and proxy voting, in accordance with the applicable regulations. For further information, shareholders are invited to consult the documents made available on the Company's website: ABOUT OSE IMMUNOTHERAPEUTICS OSE Immunotherapeutics is a biotechnology company developing first-in-class products in immuno-oncology (IO) and immuno-inflammation (I&I) to address the unmet needs of today's and tomorrow's patients. We partner with leading academic institutions and biopharmaceutical companies to combine our efforts to develop and bring to market transformative medicines for people suffering from serious diseases. OSE Immunotherapeutics is based in Nantes and Paris and is listed on Euronext. More information on OSE Immunotherapeutics' assets is available on the Company's website: Follow us on OSE Immunotherapeutics Fiona Dé French Media Contact FP2COMFlorence Portejoiefportejoie@ 6 07 768 283 Forward-looking statementsThis press release contains express or implied forward-looking information and statements about OSE Immunotherapeutics. They are not historical facts. Such information and statements include financial projections based on assumptions or suppositions made by the management of OSE Immunotherapeutics in light of their experience and perception of historical trends, current economic and industry conditions, future developments and other factors they deem forward-looking statements can often be identified by the use of the conditional tense and by the verbs "expects", "anticipates", "believes", "plans" or "estimates" and their declinations and conjugations, as well as by other similar OSE Immunotherapeutics' management believes that the expectations reflected in such forward-looking statements are reasonable, OSE Immunotherapeutics' shareholders and other investors are cautioned that the realization of such expectations is subject to numerous risks and uncertainties, known and unknown, that are difficult to predict and that are beyond OSE Immunotherapeutics' control. These risks could cause actual results and developments to differ materially from those expressed or implied in such forward-looking statements. These risks include, but are not limited to, those discussed or identified in the public filings made by OSE Immunotherapeutics with the AMF. Such forward-looking statements are not guarantees of future press release includes summary information only and should be read in conjunction with OSE Immunotherapeutics' Universal Registration Document, registered by the AMF on 30 April 2024, including the 2023 annual financial report, available on OSE Immunotherapeutics' Immunotherapeutics does not undertake any obligation to update any forward-looking information or statements at any particular as required by applicable laws and regulations. 1 s2 Attachment EN_OSE - CP Documents AG 2025_VFError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
02-06-2025
- Business
- Yahoo
AFYREN: Availability of Preparatory Documents for the Combined General Meeting on June 17, 2025
E-voting available (VOTACCESS) from June 2, 2025, to June 16, 2025 (03:00 pm CEST) CLERMONT-FERRAND, France & LYON, France, June 02, 2025--(BUSINESS WIRE)--Regulatory News: AFYREN (Paris:ALAFY), a greentech company offering industrial customers bio-based, low-carbon products through its unique fermentation technology based on a circular model, today announced its Combined General Meeting will be held Tuesday, June 17, 2025, at 3:30 pm CEST, at the Company's office: Le Silex2 - City, 9 rue des Cuirassiers - 69003 Lyon. The preparatory documents for this General Meeting are available on the Company's website, in the Documentation / General Meetings section. The text of the resolutions was published in the meeting notice, published in the "Bulletin des Annonces Légales Obligatoires" (BALO) No. 57 of May 12, 2025. To submit their votes, shareholders may, in accordance with the procedures described in the meeting notice published in the BALO on May 12, 2025: attend the Meeting in person; vote by internet via the secure voting platform VOTACCESS; vote by mail; give proxy to the Chairman of the Meeting or to any other person of their choice. About AFYREN AFYREN is a French greentech company, founded in 2012, focused on providing innovative, sustainable solutions to reduce reliance on fossil-based resources. AFYREN's proprietary, nature-inspired fermentation technology valorizes local biomass from non-food agricultural co-products to produce 100% biobased, low-carbon carboxylic acids. The company's sustainable solutions address decarbonization challenges in a wide variety of strategic sectors, including human and animal nutrition, flavors and fragrances, life sciences, materials science, plus lubricants and technical fluids. AFYREN's competitive, plug-and-play, circular technology enables manufacturers to adopt sustainable solutions without modifying production processes. The company's first industrial plant, AFYREN NEOXY, a joint venture with Bpifrance's SPI fund, is based in the Grand-Est region of France, serving primarily the European market. AFYREN is also pursuing a project in Thailand with a global leader in the sugar industry and is building its presence in the Americas, based on existing distribution agreements. At the end of 2024, AFYREN employed 130 people across sites in Lyon, Clermont-Ferrand and Carling Saint-Avold. Committed to continuous innovation, the company invests 20% of its annual budget in R&D to further develop the range of sustainable solutions. AFYREN is listed on Euronext Growth® Paris since 2021 (ISIN code: FR0014005AC9, ticker: ALAFY). For more information, visit and follow us on LinkedIn View source version on Contacts AFYRENCommunicationCaroline Investor RelationsMark Reinhardinvest@ NewCapInvestor RelationsThéo Martin / Mathilde BohinTél : 01 44 71 94 94afyren@ NewCapMedia RelationsNicolas MerigeauTél : 01 44 71 94 98afyren@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
02-06-2025
- Business
- Business Wire
AFYREN: Availability of Preparatory Documents for the Combined General Meeting on June 17, 2025
CLERMONT-FERRAND, France & LYON, France--(BUSINESS WIRE)--Regulatory News: AFYREN (Paris:ALAFY), a greentech company offering industrial customers bio-based, low-carbon products through its unique fermentation technology based on a circular model, today announced its Combined General Meeting will be held Tuesday, June 17, 2025, at 3:30 pm CEST, at the Company's office: Le Silex2 - City, 9 rue des Cuirassiers - 69003 Lyon. The preparatory documents for this General Meeting are available on the Company's website, in the Documentation / General Meetings section. The text of the resolutions was published in the meeting notice, published in the ' Bulletin des Annonces Légales Obligatoires ' (BALO) No. 57 of May 12, 2025. To submit their votes, shareholders may, in accordance with the procedures described in the meeting notice published in the BALO on May 12, 2025: attend the Meeting in person; vote by internet via the secure voting platform VOTACCESS; vote by mail; give proxy to the Chairman of the Meeting or to any other person of their choice. About AFYREN AFYREN is a French greentech company, founded in 2012, focused on providing innovative, sustainable solutions to reduce reliance on fossil-based resources. AFYREN's proprietary, nature-inspired fermentation technology valorizes local biomass from non-food agricultural co-products to produce 100% biobased, low-carbon carboxylic acids. The company's sustainable solutions address decarbonization challenges in a wide variety of strategic sectors, including human and animal nutrition, flavors and fragrances, life sciences, materials science, plus lubricants and technical fluids. AFYREN's competitive, plug-and-play, circular technology enables manufacturers to adopt sustainable solutions without modifying production processes. The company's first industrial plant, AFYREN NEOXY, a joint venture with Bpifrance's SPI fund, is based in the Grand-Est region of France, serving primarily the European market. AFYREN is also pursuing a project in Thailand with a global leader in the sugar industry and is building its presence in the Americas, based on existing distribution agreements. At the end of 2024, AFYREN employed 130 people across sites in Lyon, Clermont-Ferrand and Carling Saint-Avold. Committed to continuous innovation, the company invests 20% of its annual budget in R&D to further develop the range of sustainable solutions. AFYREN is listed on Euronext Growth ® Paris since 2021 (ISIN code: FR0014005AC9, ticker: ALAFY).
